These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34453535)

  • 1. Efficacy of dihydroartemisinin/piperaquine in patients with non-complicated Plasmodium falciparum malaria in Yaoundé, Cameroon.
    Mairet-Khedim M; Nsango S; Ngou C; Menard S; Roesch C; Khim N; Srun S; Iriart X; Lanot T; Otam L; Abega F; Ayong L; Morlais I; Gandia P; Witkowski B; Berry A
    J Antimicrob Chemother; 2021 Oct; 76(11):3037-3044. PubMed ID: 34453535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.
    van der Pluijm RW; Imwong M; Chau NH; Hoa NT; Thuy-Nhien NT; Thanh NV; Jittamala P; Hanboonkunupakarn B; Chutasmit K; Saelow C; Runjarern R; Kaewmok W; Tripura R; Peto TJ; Yok S; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Lek D; Huy R; Dhorda M; Chotivanich K; Ashley EA; Mukaka M; Waithira N; Cheah PY; Maude RJ; Amato R; Pearson RD; Gonçalves S; Jacob CG; Hamilton WL; Fairhurst RM; Tarning J; Winterberg M; Kwiatkowski DP; Pukrittayakamee S; Hien TT; Day NP; Miotto O; White NJ; Dondorp AM
    Lancet Infect Dis; 2019 Sep; 19(9):952-961. PubMed ID: 31345710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
    Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
    Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of dihydroartemisinin/piperaquine and artesunate monotherapy for the treatment of uncomplicated Plasmodium falciparum malaria in Central Vietnam.
    Rovira-Vallbona E; Van Hong N; Kattenberg JH; Huan RM; Hien NTT; Ngoc NTH; Guetens P; Hieu NL; Mai TT; Duong NTT; Duong TT; Phuc BQ; Xa NX; Erhart A; Rosanas-Urgell A
    J Antimicrob Chemother; 2020 Aug; 75(8):2272-2281. PubMed ID: 32437557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study.
    Witkowski B; Duru V; Khim N; Ross LS; Saintpierre B; Beghain J; Chy S; Kim S; Ke S; Kloeung N; Eam R; Khean C; Ken M; Loch K; Bouillon A; Domergue A; Ma L; Bouchier C; Leang R; Huy R; Nuel G; Barale JC; Legrand E; Ringwald P; Fidock DA; Mercereau-Puijalon O; Ariey F; Ménard D
    Lancet Infect Dis; 2017 Feb; 17(2):174-183. PubMed ID: 27818097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study.
    Amato R; Lim P; Miotto O; Amaratunga C; Dek D; Pearson RD; Almagro-Garcia J; Neal AT; Sreng S; Suon S; Drury E; Jyothi D; Stalker J; Kwiatkowski DP; Fairhurst RM
    Lancet Infect Dis; 2017 Feb; 17(2):164-173. PubMed ID: 27818095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.
    Amaratunga C; Lim P; Suon S; Sreng S; Mao S; Sopha C; Sam B; Dek D; Try V; Amato R; Blessborn D; Song L; Tullo GS; Fay MP; Anderson JM; Tarning J; Fairhurst RM
    Lancet Infect Dis; 2016 Mar; 16(3):357-65. PubMed ID: 26774243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
    Tran TH; Dolecek C; Pham PM; Nguyen TD; Nguyen TT; Le HT; Dong TH; Tran TT; Stepniewska K; White NJ; Farrar J
    Lancet; 2004 Jan; 363(9402):18-22. PubMed ID: 14723988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into k13-propeller gene polymorphism and ex vivo DHA-response profiles from Cameroonian isolates.
    Menard S; Tchoufack JN; Maffo CN; Nsango SE; Iriart X; Abate L; Tsapi MT; Awono-Ambéné PH; Abega Mekongo FA; Morlais I; Berry A
    Malar J; 2016 Nov; 15(1):572. PubMed ID: 27887614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in The Guianas: a descriptive epidemiological study.
    Florimond C; de Laval F; Early AM; Sauthier S; Lazrek Y; Pelleau S; Monteiro WM; Agranier M; Taudon N; Morin F; Magris M; Lacerda MVG; Viana GMR; Herrera S; Adhin MR; Ferreira MU; Woodrow CJ; Awab GR; Cox H; Ade MP; Mosnier E; Djossou F; Neafsey DE; Ringwald P; Musset L
    Lancet Infect Dis; 2024 Feb; 24(2):161-171. PubMed ID: 37858325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
    Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
    Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria.
    Keating GM
    Drugs; 2012 May; 72(7):937-61. PubMed ID: 22515619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa?
    Foguim Tsombeng F; Gendrot M; Robert MG; Madamet M; Pradines B
    Malar J; 2019 Aug; 18(1):285. PubMed ID: 31443646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations.
    Duru V; Khim N; Leang R; Kim S; Domergue A; Kloeung N; Ke S; Chy S; Eam R; Khean C; Loch K; Ken M; Lek D; Beghain J; Ariey F; Guerin PJ; Huy R; Mercereau-Puijalon O; Witkowski B; Menard D
    BMC Med; 2015 Dec; 13():305. PubMed ID: 26695060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam.
    Phuc BQ; Rasmussen C; Duong TT; Dong LT; Loi MA; Ménard D; Tarning J; Bustos D; Ringwald P; Galappaththy GL; Thieu NQ
    Emerg Infect Dis; 2017 Apr; 23(4):715-717. PubMed ID: 28322709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment.
    Leang R; Taylor WR; Bouth DM; Song L; Tarning J; Char MC; Kim S; Witkowski B; Duru V; Domergue A; Khim N; Ringwald P; Menard D
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4719-26. PubMed ID: 26014949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
    Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
    Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam.
    Thanh NV; Thuy-Nhien N; Tuyen NT; Tong NT; Nha-Ca NT; Dong LT; Quang HH; Farrar J; Thwaites G; White NJ; Wolbers M; Hien TT
    Malar J; 2017 Jan; 16(1):27. PubMed ID: 28086775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.